Infectious Diseases News Index

 
 
  • S. Africa on Alert After Fatal Bleeding Sickness South African health authorities are on high alert after three people died in hospital from an unknown, infectious disease similar to hemorrhagic fever, health officials said.
  • Obama's Healthcare Plan Insures More People Than McCain's, Study Says Twice as many uninsured people in the United States will have health insurance in 10 years under Sen. Barack Obama's healthcare plan than under Sen. John McCain's plan, according to a report by the Commonwealth Fund, but a critic challenges the group's projections.
  • Hepatitis B Virus Associated With Pancreatic Cancer Exposure to the hepatitis B virus could increase the risk for pancreatic cancer, and chemotherapy treatment might cause reactivation of the virus in cancer patients.
  • FDA Mulls Limits on Kids' Cough Medicine Some experts want to end sales of over-the-counter cough and cold medicine for children.
  • CME/CE Infectious Gastroenteritis May Trigger Onset of Inflammatory Bowel Disease By disrupting normal intestinal homeostatic mechanisms through subclinical inflammation and immune activation, acute enteric infections may increase the risk of inflammatory bowel disease.
  • Untreated HIV-1 Infection Does Not Impair Semen Quality Prolonged, untreated HIV-1 infection does not appear to impair semen quality, according to a report in the September issue of Fertility and Sterility.
  • New Short-Course Regimen Useful for Kala-Azar A single dose of liposomal amphotericin followed by oral miltefosine for 7 to 14 days is a safe and effective treatment for kala-azar, also know as visceral leishmaniasis, according to results of a study from India.
  • AHRQ Awards $3 Million to Reduce Central Line-Associated Bloodstream Infections The Agency for Healthcare Research and Quality has awarded $3 million to a nationwide project to help prevent central line-associated bloodstream infections in hospital intensive care units.
  • Half a Billion Have Genital Herpes Virus The World Health Organization has published the first global prevalence and incidence estimates of herpes simplex virus type 2 infection.
  • Progressive Multifocal Leukoencephalopathy Still an Important Infection in AIDS Patients Progressive multifocal leukoencephalopathy (PML) "continues to be one of the deadliest opportunistic infections in acquired immunodeficiency syndrome patients," Spanish investigators report in the September 1 issue of the Journal of Acquired Immune Deficiency Syndromes.
  • Moxifloxacin Has "Incredibly Rapid" Response Rates in Leprosy Moxifloxacin is a "powerful" antimicrobial in the treatment of leprosy, researchers at the Leonard Wood Memorial Center for Leprosy Research in Cebu, Philippines, report in the September issue of Antimicrobial Agents and Chemotherapy.
  • HIV Prevalence in US Tops 1 Million The US Centers for Disease Control and Prevention estimate that approximately 1.1 million adults and adolescents in the US were living with HIV infection at the end of 2006, according to an article in the Morbidity and Mortality Weekly Report for October 3.
  • S. Africa Health Minister Vows to Make AIDS Priority South Africa's new health minister Barbara Hogan vowed on Thursday to make AIDS a top priority, after years of controversy over her predecessor's unconventional support for treatments like beetroot and garlic.
  • Work Absences for Major Illness Linked to Mortality Employees who take off work for major illnesses are at increased risk for death, new research suggests. The exception, however, is absences due to musculoskeletal disease, which show no association with mortality.
  • News Media Often Omit Potential Sources of Bias in Medical Research News media often do not report sources of funding for medical research; they also often refer to drugs by brand name and lack formal policies regarding reporting on these potential sources of bias.
  • Maraviroc Safe, Effective for Previously Treated Patients With R5 HIV-1 Infection Maraviroc reduces viral load and improves CD4 cell counts when added to optimized background therapy in treatment-experienced patients infected with R5 HIV-1, according to the results of two multinational phase III clinical trials reported in the October 2 issue of The New England Journal of Medicine.
  • Nevirapine-Based HAART May Be Harmful in Pregnancy Serious toxicity appears to be associated with continuous nevirapine-based highly active antiretroviral therapy (HAART) in HIV-positive pregnant women, according to Canadian researchers.
  • FDA Reassures About Safety of Gardasil Once Again The FDA has issued a consumer leaflet about the human papillomavirus vaccine Gardasil, reiterating that it continues to find that "benefits outweigh the risks"
  • New Institute to Focus on AIDS Vaccine A new AIDS vaccine research center dedicated to solving one of the most difficult problems holding back development of an HIV vaccine will open in California, researchers announced on Tuesday.
  • Albendazole Improves Immunity in Helminth/HIV-1 Coinfection Albendazole treatment increases CD4 cell counts in patients coinfected with Ascaris lumbricoides and HIV-1, a multicenter team reports.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.